drugset / Trial / NCT03393481
Prevention of Thromboembolic Events in Total Knee Replacement Patients
NaParallel-groupSingle-blindPrevention
Summary
The purpose of the study is to find out whether MAA868, is able to prevent blood clots following your medical condition (surgery for knee replacement)
Timeline
- Start
- 2018-10-03
- Primary completion
- 2020-01-08
- Completion
- 2020-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abelacimab | Monoclonal antibody | — | Subcutaneous |
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |